• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONVATEC DOMINICAN REPUBLIC INC L3W0750 - DUODERM; DRESSING,WOUND,OCCLUSIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONVATEC DOMINICAN REPUBLIC INC L3W0750 - DUODERM; DRESSING,WOUND,OCCLUSIVE Back to Search Results
Model Number 187661
Device Problems Delivered as Unsterile Product (1421); Unsealed Device Packaging (1444); Packaging Problem (3007)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
Device 2 of 6.Complainant street address: (b)(6).Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number (b)(4).
 
Event Description
It was reported that there were six units which had an incorrect sealing and the packaging were almost opened.The product was not used by customer.Photographs depicting the issue were received from the complainant.
 
Manufacturer Narrative
Additional information - this emdr is being submitted to include the below: h6: investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions h10: investigation summary returned sample evaluation: photograph associated with this case was received for evaluation.Investigation summary: on 27/dec/2022, complaint investigator, ran a query in database, looking for open child investigations, generated for the failure mode ¿primary pack (sterile products) has incomplete or open seal / weld, or is torn, ripped or contains holes or exhibits external contamination (e.G.Water marks, stains), or dressing or loose material is trapped in packaging¿, for products manufactured at the bopack manufacturing lines on convatec haina; three (3) complaints were found opened pending for investigation.Bounding & rationale: batch record review was performed to the batch record of finished goods and subassembly, all the components utilized were correct per bill of materials (bom), under applicable international commodity code (icc) code and erp material.The testing results were found satisfactory and the crew requirements and responsibilities, process parameters, tooling¿s, quality and in-process inspections, line operations, process troubleshooting and relevant documents to the process were run according to the applicable process instruction.During the batch record review process, it was identified that these batches had no deviations, nonconformities, corrections, or corrective and preventive actions (capa) within the quality system.The applicable quality tests performed to these batches based on the process instruction and device specification.All the components for assembly were correct per bill of materials (bom), and the machine parameters and tooling information documented was also correct.Customer complaint review: complaint investigator ran a query in database in order to verify the complaints reported for the batches involved in this study and as result, for lot 1b01354 five (05) additional complaint were found, however, these complaints are not related to the malfunction code involved in this evaluation and for lot 1c04840 one (01) additional complaint was found, however, these complaints are not related to the malfunction code involved in this evaluation.Nonconformance review: on 27/dec/2022, complaint investigator ran a query in database in order to verify if any nonconformance associated with the defect reported for the customer was generated in the bopack manufacturing lines from 01/jan/2021 to 27/dec/2022 and as result (01) nonconformance was found.Through the preliminary investigation of record, the root cause was identified, and containment and actions were taken to mitigate the identified issue.The actions taken during the investigation for record were performed after the manufacturing date of lots impacted in this memo.Through the preliminary investigation of the ncr, it was determined the following causes: as per preliminary investigation result, it was concluded that the defect of open seal in the primary packaging in the bopack line is related to: method.In case of the open seal defect in the sealing station, after a triage team and operators of the line interviews, it was defined that the condition occurs when cutter get in contact with the mass and dirt.This adhesive mass blocks the normal machine flow of packaging materials.Therefore, it provokes variation of position where materials are cut.Based on this rationale, this issue was related to dressing placement.A revision of the process instruction was performed, and it was not found a defined method to dressing placement operation.A corrective and preventive actions (capa) plan was generated to address the cause identified within this preliminary investigation.As part of the nonconformance and corrective and preventive actions (capa), the followings actions were taken: created a job aid to describe the correct method on how to place dressing on the machine.Completed on 25/may/2022.Containment & corrections: according to system application product (sap) system, there are a total of (b)(4); this occurrence is within our accepted acceptable quality limit (aql) level for this type of failure mode or defect, therefore no stop shipment and no health hazard evaluations (hhe) is required.Personnel involved was notified about the issue.Completed on 06/apr/2022.No additional containment is needed based on this correction was performed under the event.Conclusions: based on the batch record review performed, no issues related to the failure mode reported were found within the documentation.Since photos were received, the complaint could be confirmed.In addition, no further complaints have been received for this failure mode in this line after corrective and preventive actions implementation.After the manufacturing of the batch reported a nonconformance for the same failure mode and line was generated related to complaint reported (31/mar/2022) and through event the probable cause of the issue was identified, and the applicable actions were taken.For this reason, no additional actions are required.This failure mode will keep monitored for track and trend.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 9618003.
 
Event Description
To date no additional patient or event details have been received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
L3W0750 - DUODERM
Type of Device
DRESSING,WOUND,OCCLUSIVE
Manufacturer (Section D)
CONVATEC DOMINICAN REPUBLIC INC
km 18.5 parque industrial
itabo, s.a. haina
san cristobal 91000
DR  91000
Manufacturer (Section G)
CONVATEC DOMINICAN REPUBLIC INC
km 18.5 parque industrial
itabo, s.a. haina
san cristobal 91000
DR   91000
Manufacturer Contact
pamela meadows
7815 national service road
suite 600
greensboro, NC 
3365424679
MDR Report Key14191755
MDR Text Key289960611
Report Number9618003-2022-00517
Device Sequence Number1
Product Code NAD
UDI-Device Identifier00768455174881
UDI-Public00768455174881
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number187661
Device Lot Number1C04840
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/01/2022
Was the Report Sent to FDA? Yes
Date Manufacturer Received01/14/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-